The addition of recombinant rat interleukin-5 (IL-5), which was purified from the hemolymph of silkworm Bombyx mori larvae infected with IL-5-expressing recombinant virus, to cultures of rat bone marrow cells resulted in an increase in the number of Luxol-fast-blue staining eosinophils in a time-and concentration-dependent manner. After 6 days culture with 100 pM recombinant rat IL-5, more than 90% of the bone marrow cells were eosinophil. The contents of major basic protein (MBP) in the bone marrow cells determined by Western blot analysis using a polyclonal antibody to rat MBP were also increased by recombinant rat IL-5 (100 pM). Furthermore, intravenous injections of recombinant rat IL-5 twice a day for six consecutive days increased the population of eosinophils in peripheral blood cells and in bone marrow cells. These findings indicate that rat IL-5 induces terminal differentiation and proliferation of progenitor cells to mature eosinophils in rats. ß
Introduction
Eosinophils are suggested to play important roles in the pathogenesis of allergic in£ammation such as bronchial asthma and atopic dermatitis [1^4] . In patients su¡ering from asthma, the number of eosinophils in bone marrow and peripheral blood and at the in£ammatory site is increased [5^8] . At the in£ammatory site, in¢ltrating eosinophils release various cytokines including interleukin-1 (IL-1), IL-4, IL-8, IL-10 and interferon-Q, regulated upon activation in normal T cells expressed and secreted (RANTES) and macrophage in£ammatory protein-1K [9] and mediators such as leukotriene C 4 [101 2], platelet-activating factor [13, 14] and granule proteins including major basic protein (MBP), eosinophil cationic protein, eosinophil-derived neurotoxin and eosinophil peroxidase [15^17] , resulting in the tissue damage and bronchial hyperresponsiveness [12,14^17] .
IL-5 is produced mainly by activated T cells and mast cells [18] . In humans, IL-5 shows various biological activities such as eosinophil di¡erentiation factor (EDF) activity [19^22] and eosinophil survival-enhancing activity [23] . The terminal di¡erentia-tion and the proliferation of progenitor cells to mature eosinophils are induced by EDF activity of 24, 25] , resulting in the increase in the number of eosinophils in allergic in£ammation [26^28] . Recently, we have prepared recombinant rat IL-5 from the hemolymph of silkworm Bombyx mori (B. mori) larvae infected with cysteine proteinase-deleted virus containing cDNA for rat IL-5 [25] and found that recombinant rat IL-5 possesses EDF activity using the methylcellulose-culture system [24] of rat bone marrow cells [25] . However, in rat species, it has not been clari¢ed whether the generation of rat eosinophils is induced by rat IL-5 in vivo. In the present study, we examined whether the recombinant rat IL-5 increases the number of eosinophils in liquid culture of rat bone marow cells and in vivo.
Materials and methods

Collection of rat bone marrow cells
Bone marrow cells were collected from thighbones and shinbones of rats (Sprague^Dawley strain, male, speci¢c pathogen-free, weighing 200^250 g, Charles River Japan, Kanagawa, Japan) as described previouly [29] . The rats were treated in accordance with procedures approved by the Animal Ethics Committee of the Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. After 3 washes with minimum essential medium alpha (KMEM, Gibco-BRL, Gaithersburg, MD, USA), the bone marrow cells were used for the subsequent experiments.
Culture of rat bone marrow cells
Bone marrow cells were suspended at 4U10 5 cells/ ml in KMEM containing 30% (v/v) fetal bovine serum (FBS, Flow Laboratories, North Rydge, NSW, Australia), 1% (w/v) bovine serum albumin (BSA, Sigma, St. Louis, MO, USA) and the various concentrations of recombinant rat IL-5. The recombinant rat IL-5 was prepared from the hemolymph of silkworm B. mori larvae infected with cysteine proteinase-deleted virus containing cDNA for rat IL-5 as described previously [25] . Five milliliters of the cell suspension was poured into each well of a 6-well culture dish (Corning, Corning, NY, USA) and incubated at 37³C in a humidi¢ed atmosphere of 5% CO 2 in air. After incubation, the cells were harvested and the total number of cells that excluded Trypan blue dye was determined using a hemocytometer. A portion of the cells was smeared on a slide glass and stained with Luxol-fast-blue (EM Science, Cherry Hill, NJ, USA) and hematoxylin (Merck, Darmstadt, Germany) to identify eosinophils and the percentage of eosinophils was calculated. The total number of eosinophils was then determined.
Immunoblotting for MBP
Rat MBP was detected by a modi¢cation of the method described by Nittoh et al. [30] . After incubation for 3 and 6 days in the presence and absence of recombinant rat IL-5 (100 pM), bone marrow cells (1U10 5 cells) were boiled for 5 min in loading bu¡er (31.25 mM Tris^HCl (pH 6.8), 1% (w/v) sodium dodecylsulfate, 10% (v/v) glycerol, 5% (v/v) 2-mercaptoethanol and 0.01% (w/v) bromophenol blue), applied to a 15% (w/v) polyacrylamide gel and subjected to electrophoresis at 125 V for 2 h. After electrophoresis, proteins in the gel were transferred onto a nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany). Non-speci¢c binding sites were blocked by incubation for 1 h at room temperature in Block Ace (Dainippon, Osaka, Japan). The membrane was then incubated for 12 h at 4³C with rabbit anti-MBP antibody [30] at a concentration of 0.1 Wg/ml. After 3 washes, the membrane was incubated at 4³C for 3 h with a 1:5,000 dilution of biotinylated anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA). The reaction products were incubated for 30 min at room temperature with ABC reagent (Vector Laboratories) and visualized by ECL Systems (Amersham Pharmacia Biotech, Buckinghamshire, UK). The membrane was exposed to a Kodak X-Omat AR ¢lm (Eastman Kodak, Rochester, NY, USA) for 5 min at room temperature.
Detection of eosinophils in peripheral blood and bone marrow of rats
Rats (Sprague^Dawley strain, male, speci¢c pathogen-free, weighing 200^250 g, Charles River Japan) received intravenous injections of the sterilized saline containing 0.01% (w/v) BSA in the presence or absence of 10 nM recombinant rat IL-5 at a dose of 10 pmol/kg at intervals of 12 h for 6 days. Control rats received the saline solution without recombinant rat IL-5 in the same way. Bone marrow cells from thighbones and shinbones and peripheral blood were collected 12 h after the last injection of the recombinant rat IL-5. The percentage of eosinophils in bone marrow cells and in white blood cells was identi¢ed after staining with Luxol-fast-blue and hematoxylin.
Statistical analysis
The statistical signi¢cance of the results was analyzed by Dunnett's test for multiple comparison.
Results
Time-course of the e¡ects of recombinant rat
IL-5 on the number of eosinophils in rat bone marrow cells
We examined whether the recombinant rat IL-5 increases the number of eosinophils. Before incubation, the number of eosinophils in 2.0U10 6 bone marrow cells was (10.6 þ 1.1)U10 4 cells (Fig. 1 ). When the bone marrow cells were incubated in the absence of recombinant rat IL-5, the number of total cells and eosinophils was decreased time-dependently (Fig. 1A) . After 6 days incubation of the bone marrow cells in the absence of recombinant rat IL-5, the number of total cells and eosinophils was (11.8 þ 1.0)U10 4 and (0.6 þ 0.1)U10 4 cells, respectively (Fig. 1A) . In contrast, the number of eosino- 6 cells) were incubated at 37³C for 6 days in 5 ml of KMEM supplemented with 30% FBS and 1% BSA containing the indicated concentrations of recombinant rat IL-5. After incubation for 6 days, the number of total cells was counted using a hemocytometer and the total number of eosinophils was calculated as follows: total number of eosinophils = (number of total cells) U(eosinophils (%))U0.01. Values are the means from 6 samples with S.E.M. shown by vertical bars. Statistical signi¢cance: *P 6 0.05, **P 6 0.01, ***P 6 0.001 versus before incubation (day 0); ## P 6 0.01, ### P 6 0.001 versus after 6 days incubation without rat IL-5.
phils increased time-dependently by 100 pM recombinant rat IL-5 (Fig. 1B) . A signi¢cant increase in the number of eosinophils was observed from 3 days after incubation. In the presence of recombinant rat IL-5, the number of total cells decreased up to 3 days, but re£ecting the increase in the number of eosinophils, the number of total cells did not decrease after 3 days (Fig. 1B) . After 6 days incubation of the bone marrow cells in the presence of recombinant rat IL-5, the number of total cells and eosinophils was (69.5 þ 2.6)U10 4 and (63.9 þ 3.9)U10 4 cells, respectively. More than 90% in rat bone marrow cells were eosinophils.
E¡ects of recombinant rat IL-5 on the number of eosinophils in rat bone marrow cells
When rat bone marrow cells were incubated at 37³C for 6 days in the absence of recombinant rat IL-5, the number of eosinophils decreased compared with that before incubation (Fig. 2) . In contrast, the presence of recombinant rat IL-5 increased the number of eosinophils in a concentration-dependent manner (Fig. 2) . A signi¢cant increase in the number of eosinophils was observed at 10 and 100 pM recombinant rat IL-5 (Fig. 2) . Microscopic observation also revealed that recombinant rat IL-5 (100 pM) increases the number of eosinophils in bone marrow cells when examined 6 days after incubation (Fig. 3) . These ¢ndings indicate that recombinant rat IL-5 increases the number of eosinophils in rat bone marrow cells in vitro. 
Detection of rat MBP in cultured bone marrow cells
We analyzed whether the increase in the number of eosinophils is accompanied with the expression of MBP in bone marrow cells. When the bone marrow cells were incubated for 6 days in the absence of recombinant rat IL-5, the content of MBP in the bone marrow cells was decreased compared with that in the cells before incubation (Fig. 4) . In contrast, the content of MBP was signi¢cantly increased by 100 pM recombinant rat IL-5, 3 and 6 days after incubation (Fig. 4) . These ¢ndings indicate that the increase in the number of eosinophils by recombinant rat IL-5 is accompanied with the expression of MBP.
E¡ects of intravenous injection of recombinant rat IL-5 on the population of eosinophils in peripheral blood and bone marrow
To analyze whether the recombinant rat IL-5 induces eosinophilia, rats received intravenous injections of recombinant rat IL-5 at a dose of 10 pmol/kg at intervals of 12 h for 6 days and the percentage of eosinophils in peripheral blood cells and in bone marrow cells were determined. When rats were injected intravenously with saline solution containing no recombinant rat IL-5, the percentage of eosinophils in peripheral blood cells and in bone marrow cells did not signi¢cantly change when compared with that before injection of IL-5 (Fig. 5) . In contrast, the repeated injection of recombinant rat IL-5 increased the percentage of eosinophils in peripheral blood cells and in bone marrow cells (Fig.  5) . A signi¢cant increase in the percentage of eosinophils in peripheral blood cells and in bone marrow cells was also observed 3 days after injection (data not shown). These ¢ndings indicate that the repeated intravenous injection of recombinant rat IL-5 induces eosinophilia in rats.
Discussion
It is reported that human IL-5 and mouse IL-5 induce the generation of mature eosinophils from precursor cells in vitro in each species [19^22] . The present paper is the ¢rst to report that recombinant rat IL-5 [25] generates mature eosinophils from precursor cells in rats in vitro and in vivo.
Rats are useful animals for the analysis of allergic in£ammation [25,30^34] . Nittoh et al. [30] reported that the intraperitoneal injection of Ascaris suum antigen to the immunized rats increases the number of eosinophils in peripheral blood and in bone marrow. Underwood et al. [31] showed that the inhalation of the antigen ovalbumin causes the expression of IL-5 mRNA in lung tissue and the in£ux of eosinophils into lung tissue and airway lumen. Recently, we [25] reported that recombinant rat IL-5 induces eosinophilic colony formation in rat bone marrow cells and enhances survival of eosinophils. Therefore, in rat species, it is very possible that IL-5 contributes to eosinophilia as in human and mouse species [5^8,26^28]. To prove this possibility, we examined the e¡ect of recombinant rat IL-5 on the generation of eosinophils in vitro and in vivo. Preliminary experiments revealed that rat neutrophils and macrophages isolated from the peritoneal cavity [35, 36] are not stained with Luxol-fast-blue which speci¢cally binds to granule proteins of human eosinophils [37] . Therefore, in this paper, we identi¢ed rat eosinophils by staining with Luxol-fast-blue. As shown in Fig. 4 , the content of rat MBP determined by using the polyclonal antibody to rat MBP [30] was increased by recombinant rat IL-5, in parallel with the increase in the number of Luxol-fast-bluepositive cells in bone marrow cells (Fig. 1) . Because MBP is a speci¢c granule protein in eosinophils [38] , it is strongly indicated that the Luxol-fast-blue-positive cells in rats are eosinophils and recombinant rat IL-5 induces generation of eosinophils from progenitor cells in vitro.
It is reported that IL-5 and granulocyte colonystimulating factor (G-CSF) di¡erentiate and proliferate the stem cells to eosinophils in humans and in mice [20, 24] . Ema et al. [39] reported that, in humans, IL-3 and G-CSF di¡erentiate CD33 CD34 stem cells to CD33 CD34 3 stem cells, while IL-5 di¡erentiates and proliferates only CD33 CD34 3 stem cells to mature eosinophils. These reports suggest that IL-5 supports the late-stage di¡erentiation of eosinophils. In the present study, we observed that the number of eosinophils in the bone marrow cells was increased by recombinant rat IL-5 (Figs. 1^3) . Therefore, it is suggested that CD33 CD34 3 stem cells in rat bone marrow cells might have responded to the recombinant rat IL-5. Yamaguchi et al. [40] reported that the expression of MBP gene in human eosinophils is regulated by several transcription factors including GATA1, GATA2, C/EBPK and C/ EBPL. In C/EBPK-de¢cient mice, the development of eosinophils and the expression of G-CSF receptors are impaired [41] . Mu « ller et al. [42] also showed that NF-M, a chicken homolog of C/EBPL, induces eosinophil di¡erentiation in human hematopoietic progenitor cells. The stimulation of eosinophils by IL-5, GM-CSF or LTB 4 activates the JAK/STAT pathway, the p44/42 MAP kinases pathway or the PI 3-kinase/Akt pathway, but the activation of p44/ 42 MAP kinases is not related to the eosinophil survival, aggregation, arachidonic acid release and H 2 O 2 generation ( [43, 44] , Ishihara et al., submitted for publication). However, transcription factor C/ EBPL is activated through the p44/42 MAP kinase pathway in NIH-3T3 cells [45] . Therefore, it is possible that the activation of p44/42 MAP kinase is essential for the IL-5-induced di¡erentiation of progenitor cells to eosinophils. Further studies are required to clarify in detail the signal transduction pathway leading to di¡erentiation and proliferation of progenitor cells to eosinophils by IL-5.
